AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Invivoscribe at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Invivoscribe brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 637. Its session walks the measurable residual disease workflow from nucleic acid extraction through detection. The company makes assay kits for blood cancers and runs the LabPMM laboratory network for standardized flow cytometry and molecular testing.

OrganizationAMP 2026 Attendance
Invivoscribe
San Diego, CA
Diagnostics
Diagnostics for hematologic malignancies: assay kits plus the LabPMM laboratory network offering standardized flow cytometry and molecular testing and companion diagnostic development.
Booth
Exhibiting at Booth 637
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
4:00pm–4:50pm
From Extraction to Detection: Optimizing MRD Testing Workflows
Automating nucleic acid extraction, concentration and quantification ahead of biomarker testing in acute myeloid leukemia and solid tumors.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Invivoscribe

Tell us what you sell and we’ll find the people at Invivoscribe most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction